Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleiotropy01:33

Pleiotropy

43.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.2K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

491
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
491
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying and targeting abnormal mitochondrial localization associated with psychosis.

bioRxiv : the preprint server for biology·2026
Same author

Progress on Pharmacogenetic Tests for Antidepressant Drug Selection Requires Properly Designed Studies.

Journal of clinical psychopharmacology·2026
Same author

Tunable hydrogel-based micropillar arrays for myelination studies.

Nature methods·2026
Same author

Inherent Lipid Composition Abnormalities in Astrocytes Associated with Late-Onset Alzheimer's Disease (LOAD).

Cells·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Human iPSC-derived APOE4/4 Alzheimer´s disease astrocytes exhibit a senescent and pro-inflammatory state that compromises neuronal support.

Journal of neuroinflammation·2025

Related Experiment Video

Updated: Jan 15, 2026

Modeling Human Cerebellar Development In Vitro in 2D Structure
06:14

Modeling Human Cerebellar Development In Vitro in 2D Structure

Published on: September 16, 2022

2.0K

Increasing SOX10 Expression Overcomes Schizophrenia-Associated Early Oligodendrocyte Growth Deficits In Vitro.

Donna L McPhie1,2, Juan Antonio García-León3,4, Catherine M Verfaillie5

  • 1Harvard Medical School, Boston, Massachusetts.

Biological Psychiatry Global Open Science
|October 13, 2025
PubMed
Summary

Schizophrenia (SZ) is linked to lower brain myelin. Increasing SOX10 expression in neural cells from SZ patients restored oligodendrocyte production, suggesting SOX10 as a therapeutic target for myelin deficits.

Keywords:
Glial differentiationHuman iPS cellsMyelinOligodendrocytesSOX10Schizophrenia

More Related Videos

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
10:53

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions

Published on: November 9, 2020

5.4K
Author Spotlight: Collecting Neural Stem and Progenitor Cells from Live Animals Using a Novel Brain Milking Protocol
06:52

Author Spotlight: Collecting Neural Stem and Progenitor Cells from Live Animals Using a Novel Brain Milking Protocol

Published on: February 9, 2024

2.5K

Related Experiment Videos

Last Updated: Jan 15, 2026

Modeling Human Cerebellar Development In Vitro in 2D Structure
06:14

Modeling Human Cerebellar Development In Vitro in 2D Structure

Published on: September 16, 2022

2.0K
Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
10:53

Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions

Published on: November 9, 2020

5.4K
Author Spotlight: Collecting Neural Stem and Progenitor Cells from Live Animals Using a Novel Brain Milking Protocol
06:52

Author Spotlight: Collecting Neural Stem and Progenitor Cells from Live Animals Using a Novel Brain Milking Protocol

Published on: February 9, 2024

2.5K

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Individuals with schizophrenia (SZ) exhibit reduced brain myelin content.
  • Aberrant oligodendrocyte (OL) development is implicated in SZ-related myelin deficits.
  • Previous studies showed reduced OL production in SZ-derived neural lines.

Purpose of the Study:

  • To investigate the role of SOX10 in oligodendrocyte development in schizophrenia.
  • To determine if increasing SOX10 expression can correct OL production deficits in SZ-derived cells.

Main Methods:

  • Fibroblasts from SZ patients and controls were reprogrammed into neural lines.
  • Gene expression of SOX10 and related genes (OLIG2, SOX9, QKI, FEZ1) was quantified.
  • SOX10 was overexpressed in neural precursor cells to assess its impact on OL production.

Main Results:

  • SOX10 expression was significantly lower in neural lines from SZ patients.
  • Reduced expression of SOX9 and QKI was also observed in SZ-derived cells.
  • Elevated SOX10 expression successfully rescued the deficit in oligodendrocyte production.

Conclusions:

  • Reduced SOX10 is a key factor in deficient OL production in schizophrenia.
  • This SOX10 deficiency contributes to abnormal brain myelination in SZ.
  • Targeting SOX10 may offer a therapeutic strategy for schizophrenia-associated myelin abnormalities.